Form 4 for CYTK CYTOKINETICS INC
Accepted 2026-04-15 18:32:13 ET · period of report 2026-04-15 · accession 0001061983-26-000037 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-15 18:32 | 2026-04-15 | CYTK | Daly James M | Dir | A - Grant | $65.37 | +191 | 388 | +97% | +$12.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-04-15 | A | A | 191 | $65.37 | 388 | D | — | — | (F1) Shares of common stock granted pursuant to Director Equity in Lieu of Cash Retainer Program. Shares are fully vested. |